ABBV-637

· AbbVie

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABBV-637, covering 2025-07-03 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma [Phase 1]